Mexico · Delayed Price · Currency is MXN ALPEK Earnings Call Transcripts
Fiscal Year 2026
-
Operational excellence and supply chain agility drove record EBITDA and cash flow, prompting a raised 2026 outlook. Both business segments posted their best results since 2022, while asset sales and deleveraging remain priorities.
-
Q1 saw a 50% sequential EBITDA increase, driven by strong execution, asset optimization, and favorable market conditions amid geopolitical disruptions. Guidance for Q2 is robust, with further asset sales and specialty product investments expected to enhance margins.
Fiscal Year 2025
-
2025 results were impacted by global overcapacity and weak polyester margins, but operating free cash flow improved 57% year-over-year. 2026 guidance projects comparable EBITDA of $450–$500 million, with deleveraging and asset sales as top priorities.
-
Sequential EBITDA and cash flow improved, but full-year guidance was revised down due to persistent oversupply, low margins, and heavy imports. Merger approval and new U.S. tariffs on PET are expected to benefit results from 2026.
-
Second quarter results showed resilient plastics and chemicals performance offsetting polyester margin pressure from global oversupply and tariffs. Guidance was revised lower, with a focus on cost control, asset optimization, and financial flexibility.
-
Challenging market conditions led to lower volumes and EBITDA, especially in polyester, while plastics and chemicals remained stable. Strategic initiatives include asset divestments, value-added product expansion, and innovation in energy. Deleveraging and disciplined capital allocation remain priorities.
Fiscal Year 2024
-
Comparable EBITDA for 2024 exceeded guidance at $699 million, driven by cost-saving initiatives and higher container freight costs. 2025 guidance anticipates lower EBITDA of $625 million due to reduced freight rates, with a focus on further cost reductions and maintaining strong cash flow.
-
Q3 2024 results exceeded expectations with strong EBITDA, driven by high freight costs and stable demand. Guidance for 2024 EBITDA was raised, CapEx reduced, and leverage is expected to improve further. The spin-off process is progressing, and cost savings initiatives are on track.
-
Second quarter results met expectations with improved cash flow, cost reductions, and stable volumes despite operational challenges. Full-year guidance is reaffirmed, deleveraging continues, and strategic investments are prioritized, with no dividends planned for 2024.